Literature DB >> 6136666

Teratogenicity of isotretinoin.

F W Rosa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6136666     DOI： 10.1016/s0140-6736(83)90538-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  34 in total

Review 1.  Clusters of birth defects: emergency and management. A review of some publications.

Authors:  J Goujard
Journal:  Eur J Epidemiol       Date:  1999-10       Impact factor: 8.082

Review 2.  Drug-induced congenital defects: strategies to reduce the incidence.

Authors:  M De Santis; B Carducci; A F Cavaliere; L De Santis; G Straface; A Caruso
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 3.  Retinoic acid, neoplasia, differentiation and development.

Authors:  C Berry
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

4.  Implementation of the harmonized EU isotretinoin Pregnancy Prevention Programme: a questionnaire survey among European regulatory agencies.

Authors:  Ineke Crijns; Sabine Straus; Michiel Luteijn; Christine Gispen-de Wied; June Raine; Lolkje de Jong-van den Berg
Journal:  Drug Saf       Date:  2012-01-01       Impact factor: 5.606

5.  Computer Automated Structure Evaluation (CASE) of the teratogenicity of retinoids with the aid of a novel geometry index.

Authors:  G Klopman; M L Dimayuga
Journal:  J Comput Aided Mol Des       Date:  1990-06       Impact factor: 3.686

6.  Patterns and utilization of isotretinoin for acne from 1984 to 2003: is there need for concern?

Authors:  Laurent Azoulay; Driss Oraichi; Anick Bérard
Journal:  Eur J Clin Pharmacol       Date:  2006-06-22       Impact factor: 2.953

7.  Isotretinoin use and the risk of inflammatory bowel disease: a case-control study.

Authors:  Seth D Crockett; Carol Q Porter; Christopher F Martin; Robert S Sandler; Michael D Kappelman
Journal:  Am J Gastroenterol       Date:  2010-03-30       Impact factor: 10.864

Review 8.  Micronutrient supplementation in pregnancy: Who, what and how much?

Authors:  F Parisi; I di Bartolo; V M Savasi; I Cetin
Journal:  Obstet Med       Date:  2018-05-04

9.  Monitoring and avoiding drug and chemical teratogenicity.

Authors:  G Koren; S M MacLeod
Journal:  CMAJ       Date:  1986-11-15       Impact factor: 8.262

Review 10.  Developments in our understanding of the genetic basis of birth defects.

Authors:  Daniel M Webber; Stewart L MacLeod; Michael J Bamshad; Gary M Shaw; Richard H Finnell; Sanjay S Shete; John S Witte; Stephen W Erickson; Linda D Murphy; Charlotte Hobbs
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.